Similar articles

• Raloxifene prevails in STAR trial, may face easier road to acceptance than previous drugs.

  Vastag B. Vastag B. J Natl Cancer Inst. 2006 Jun 7;98(11):733-5. doi: 10.1093/jnci/djj253. J Natl Cancer Inst. 2006. PMID: 16757696 No abstract available.
• Defining the role of raloxifene for the prevention of breast cancer.

  Kalidas M, Hilsenbeck S, Brown P. Kalidas M, et al. J Natl Cancer Inst. 2004 Dec 1;96(23):1731-3. doi: 10.1093/jnci/djh345. J Natl Cancer Inst. 2004. PMID: 15572750 No abstract available.
• [Antiestrogens: mechanism of action and clinical applications].

  Barrón-González A, Arias-Martínez J, Castro-Romero I. Barrón-González A, et al. Salud Publica Mex. 2001 Nov-Dec;43(6):577-84. Salud Publica Mex. 2001. PMID: 11816234 Review. Spanish.
• Tamoxifen: an enduring star.

  Veronesi U, Maisonneuve P, Decensi A. Veronesi U, et al. J Natl Cancer Inst. 2007 Feb 21;99(4):258-60. doi: 10.1093/jnci/djk072. J Natl Cancer Inst. 2007. PMID: 17312297 No abstract available.
• Targeted antiestrogens for the prevention of breast cancer.

  Bentrem DJ, Jordan VC. Bentrem DJ, et al. Oncol Res. 1999;11(9):401-7. Oncol Res. 1999. PMID: 10821534 Review.